The number of people with susceptibility test result for rifampicin in Nigeria
Nigeria: The number of people with susceptibility test result for rifampicin was 117,519 in 2021. ◆ Volatile
Latest (2021)
117,519
Change on year
up 79.3%
World rank
5th
of 155 countries
All-time high
117,519
in 2021
All-time low
819
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Nigeria, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Nigeria is 117,519, measured in 2021. That is the highest value across all 5 years on record.
That represents a change of up 79.3% on the previous year and up 14,249.1% over five years.
Nigeria ranks 5th of 155 countries on this measure, in the top 10%.
The number of people with susceptibility test result for rifampicin in Nigeria, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 819 | — |
| 2018 | 48,309 | +5798.5% |
| 2019 | 64,505 | +33.5% |
| 2020 | 65,539 | +1.6% |
| 2021 | 117,519 | +79.3% |
Nigeria compared with similar countries
- Nigeria's 117,519 is above the median for lower middle income countries, which is 2,804, 41.9× the median. (32 countries reporting)
- Nigeria's 117,519 is above the median for Sub-Saharan Africa, which is 2,015, 58.3× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 37,878 | 819 | 64,505 | 3 |
| 2020s | 91,529 | 65,539 | 117,519 | 2 |
Countries ranked near Nigeria
More health data for Nigeria
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8137 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,301 deaths per 1,000 people (2090)
- Number of infants who die before age 1 257,921 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 14 (2025)
- Population ages 00-04, female, annual growth rate 1.14 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0711 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.17 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Nigeria?
- The number of people with susceptibility test result for rifampicin in Nigeria was 117,519 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Nigeria?
- The highest recorded value was 117,519 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Nigeria?
- The lowest recorded value was 819 in 2017.
- How does Nigeria rank for the number of people with susceptibility test result for rifampicin?
- Nigeria ranks 5th out of 155 countries with data for 2021.
- Where does this Nigeria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).